Xylem Inc.
NYSE:XYLIndustrial - Machinery
+$1.04 today
- Market cap
- $21.83B
- Beta
- 1.04
- P/E (TTM)
- 27.8
- EPS (TTM)
- $4.01
- Dividend yield
- 1.49%
Volume 2.70M
Average 2.15M
XYL Sales of Investments
Cash received from selling or redeeming investments.
Xylem Inc.NYSE: XYL
Sales of Investments · Q2 FY2026 · quarter ended Jun 2026
Sales of investments outflow shrinks to $0
Q2 FY2026 sales of investments was $0, compared with $9M a year earlier. Trailing-twelve-month sales of investments was -$12M. Over 3 fiscal years it compounded at -39.4% a year.
Context
- Sales of investments amounted to 0.1% of revenue in FY2025, down 0.3 pp from a year earlier.
- Sales of investments increased in 1 of the last 3 fiscal years.
What to watch
Whether quarterly sales of investments holds near $0 or moves back toward the trailing-twelve-month quarterly average of -$3M.
Sources:Cash FlowText generated from reported figures; not investment advice.
Sales of Investments history
USD · from the cash flow
- Latest · FY2025
- 8M USD
- Year-over-year change
- -77.1%
- 4-year CAGR
- -17.2%
| Period | Period end | Sales of Investments | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 8M | -77.1% |
| FY2024 | 2024-12-31 | 35M | +3400.0% |
| FY2023 | 2023-12-31 | 1M | -97.2% |
| FY2022 | 2022-12-31 | 36M | +111.8% |
| FY2021 | 2021-12-31 | 17M | — |
Sales of Investments vs competitors
How XYL compares with its peers on the latest reported figures
- XYL's LTM Jun 2026 sales of investments of $12M is the largest of the 9 companies compared; the peer median is $0.
- Sales of investments amounts to 0.1% of revenue for XYL, versus a peer median of 0.0%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Jun 2026 | $12M | -144.4% | -39.4% | 0.1% | |
| LTM Jun 2026 | $146K | — | — | 0.0% | |
| LTM Jul 2026 | $0 | — | — | 0.0% | |
| LTM Jun 2026 | $0 | — | — | 0.0% | |
| LTM Jun 2026 | $0 | — | — | 0.0% | |
| LTM Sep 2026 | $0 | — | — | 0.0% | |
| LTM Sep 2026 | $0 | — | — | 0.0% | |
| LTM Sep 2026 | $0 | — | — | 0.0% | |
| LTM Sep 2026 | $0 | — | — | 0.0% | |
| Peer median (excluding XYL) | $0 | — | — | 0.0% | |
Competitors are the stored peer set for XYL. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Cash Flow Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Net Income | 427M | 355M | 609M | 890M | 950M |
| Depreciation & Amortization | 245M | 236M | 436M | 562M | 575M |
| Deferred Income Tax | 10M | (64M) | (79M) | (36M) | (35M) |
| Stock-Based Compensation | 33M | 37M | 60M | 56M | 53M |
| Change in Working Capital | (136M) | (102M) | (211M) | (112M) | (333M) |
| Accounts Receivables | (72M) | (192M) | (86M) | (107M) | (55M) |
| Inventory | (167M) | (147M) | 41M | (41M) | 23M |
| Accounts Payables | 81M | 117M | 22M | 64M | (22M) |
| Other Working Capital | 22M | 120M | (188M) | (28M) | (279M) |
| Other Non-Cash Items | (41M) | 134M | 22M | (97M) | 31M |
| Operating Cash Flow | 538M | 596M | 837M | 1.26B | 1.24B |
| Capital Expenditures | (208M) | (208M) | (271M) | (321M) | (331M) |
| Acquisitions (Net) | 10M | 1M | (370M) | (188M) | (200M) |
| Purchases of Investments | 208M | (21M) | (1M) | (11M) | (49M) |
| Sales of Investments | 17M | 36M | 1M | 35M | 8M |
| Other Investing Activities | (210M) | 1M | 13M | 3M | 101M |
| Investing Cash Flow | (183M) | (191M) | (628M) | (482M) | (471M) |
| Debt Repayment | (600M) | (527M) | 118M | (284M) | (81M) |
| Common Stock Issued | 0 | 0 | 0 | 0 | 20M |
| Common Stock Repurchased | (68M) | (52M) | (25M) | (20M) | (15M) |
| Dividends Paid | (203M) | (217M) | (299M) | (350M) | (391M) |
| Other Financing Activities | 16M | 6M | 49M | 39M | (34M) |
| Financing Cash Flow | (855M) | (790M) | (157M) | (615M) | (501M) |
| Effect of Forex Changes | (26M) | (20M) | 23M | (64M) | 90M |
| Net Change in Cash | (526M) | (405M) | 75M | 102M | 358M |
| Free Cash Flow | 330M | 388M | 566M | 942M | 910M |
Xylem Inc.
NYSE:XYL
Intrinsic Alpha fair value
Locked
Current Price
$95.20
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.